Proton magnetic resonance spectroscopy with dementia.
暂无分享,去创建一个
S. Morikawa | T. Inubushi | J. Handa | I. Akiguchi | A. Shiino | A Shiino | S Morikawa | T Inubushi | J Handa | Masayuki Matsuda | M. Matsuda | I Akiguchi | M Matsuda
[1] Jimmy D Bell,et al. Proton MR spectroscopy in herpes simplex encephalitis: assessment of neuronal loss. , 1990, Journal of computer assisted tomography.
[2] J. Coyle,et al. The neurobiology of N-acetylaspartylglutamate. , 1988, International review of neurobiology.
[3] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease , 1984, Neurology.
[4] P. Colletti,et al. Quantitative magnetic resonance imaging and the severity of dementia in Alzheimer's disease. , 1988, The American journal of psychiatry.
[5] P F Sharp,et al. Multimodal Imaging in Alzheimer's Disease , 1990, British Journal of Psychiatry.
[6] J. Coyle,et al. Seizures decrease regional enzymatic hydrolysis of N-acetyl-aspartylglutamate in rat brain , 1989, Brain Research.
[7] D. Menon,et al. Proton MR spectroscopy and imaging of the brain in AIDS: evidence of neuronal loss in regions that appear normal with imaging. , 1990, Journal of computer assisted tomography.
[8] B C Bowen,et al. MR signal abnormalities in memory disorder and dementia. , 1990, AJNR. American journal of neuroradiology.
[9] J. Coyle,et al. N‐Acetyl‐Aspartyl‐Glutamate: Regional Levels in Rat Brain and the Effects of Brain Lesions as Determined by a New HPLC Method , 1984, Journal of neurochemistry.
[10] B. Holman,et al. Cerebral perfusion imaging in Alzheimer's disease. Use of single photon emission computed tomography and iofetamine hydrochloride I 123. , 1987, Archives of neurology.
[11] A. Brancati,et al. Distribution of N-acetylaspartate, N-acetylaspartylglutamate, free glutamate and aspartate following complete mesencephalic transection in rat neuraxis , 1990, Neuroscience Letters.
[12] J. Frahm,et al. Localized proton NMR spectroscopy in different regions of the human brain in vivo. Relaxation times and concentrations of cerebral metabolites , 1989, Magnetic resonance in medicine.
[13] S. Gauthier,et al. Antemortem laboratory diagnosis of Alzheimer's disease , 1986, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[14] Der,et al. Age-dependent changes in localized proton and phosphorus MR spectroscopy of the brain. , 1990, Radiology.
[15] P. Hecke,et al. Human brain proton localized NMR spectroscopy in multiple sclerosis , 1991, Magnetic resonance in medicine.
[16] J. Coyle,et al. Dipeptides of glutamate and aspartate may be endogenous neuroexcitants in the rat hippocampal slice , 1985, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[17] A. Alavi,et al. Comparison of CT, MR, and PET in Alzheimer's dementia and normal aging. , 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[18] P. Narayana,et al. Serial proton magnetic resonance spectroscopy of ischemic brain injury in humans. , 1990, Investigative radiology.
[19] J. Coyle,et al. N-acetylaspartylglutamate: an endogenous peptide with high affinity for a brain "glutamate" receptor. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[20] J. Coyle,et al. N-Acetylaspartylglutamate: possible role as the neurotransmitter of the lateral olfactory tract. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[21] Y. Kakimoto,et al. A Gas Chromatographic Method for the Determination of N‐Acetyl‐l‐Aspartic Acid, N‐Acetyl‐α‐ Aspartylglutamic Acid and β‐Citryl‐l‐Glutamic Acid and Their Distributions in the Brain and Other Organs of Various Species of Animals , 1981, Journal of neurochemistry.
[22] R Harrop,et al. Comparison of PET, MRI, and CT with pathology in a proven case of Alzheimer's disease , 1986, Neurology.
[23] J. Mori-Okamoto,et al. Electrophysiological and pharmacological actions of N-acetylaspartylglutamate intracellularly studied in cultured chick cerebellar neurons , 1987, Brain Research.
[24] A. Kertesz,et al. Cognition and white matter changes on magnetic resonance imaging in dementia. , 1990, Archives of neurology.
[25] J. Frahm,et al. Cerebral metabolism in man after acute stroke: New observations using localized proton NMR spectroscopy , 1989, Magnetic resonance in medicine.
[26] J. Coyle,et al. The Journal of Histochemistry and Cytochemistry Production and Characterization of Monoclonal Antibodies to N-acetyl-aspartyl-glutamate' , 2022 .
[27] C. P. Hughes,et al. A New Clinical Scale for the Staging of Dementia , 1982, British Journal of Psychiatry.
[28] P. Colletti,et al. Magnetic resonance imaging and the severity of dementia in older adults. , 1990, Archives of general psychiatry.
[29] F. Smith,et al. Nuclear Magnetic Resonance (NMR) II. Imaging in Dementia , 1985, British Journal of Psychiatry.
[30] M. Cuénod,et al. Release of N‐Acetylaspartylglutamate on Depolarization of Rat Brain Slices , 1988, Journal of neurochemistry.
[31] J. Glowinski,et al. Depolarization-evoked release of N-acetyl-L-aspartyl-L-glutamate from rat brain synaptosomes. , 1988, European journal of pharmacology.
[32] M. Mayer,et al. High concentrations of N-acetylaspartylglutamate (NAAG) selectively activate NMDA receptors on mouse spinal cord neurons in cell culture , 1986, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[33] A. Alavi,et al. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. , 1987, AJR. American journal of roentgenology.
[34] Richard H. Griffey,et al. VAPOR for solvent-suppressed, short-echo, volume-localized proton spectroscopy , 1990 .
[35] D. Loewenstein,et al. Sensitivity and specificity of positron emission tomography and magnetic resonance imaging studies in Alzheimer's disease and multi-infarct dementia. , 1989, European neurology.
[36] J. Coyle,et al. Ontogenesis of N-acetyl-aspartate and N-acetyl-aspartyl-glutamate in rat brain. , 1984, Brain research.
[37] P Gerundini,et al. Technetium-99m HM-PAO-SPECT study of regional cerebral perfusion in early Alzheimer's disease. , 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[38] J. Coyle,et al. Calcium‐Dependent Evoked Release of N[3H]Acetylaspartylglutamate from the Optic Pathway , 1988, Journal of neurochemistry.
[39] M Brant-Zawadzki,et al. MR imaging of the aging brain: patchy white-matter lesions and dementia. , 1985, AJNR. American journal of neuroradiology.
[40] P. Sharp,et al. Application of iodine-123-labeled isopropylamphetamine imaging to the study of dementia. , 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[41] C R Jack,et al. MR findings in normal-pressure hydrocephalus: significance and comparison with other forms of dementia. , 1987, Journal of computer assisted tomography.
[42] E. R. Kloet,et al. N-acetyl-aspartylglutamate: binding sites and excitatory action in the dorsolateral septum of rats , 1987, Brain Research.